Quidel’s At-Home COVID-19 Test Gets FDA EUA
Quidel has received Emergency Use Authorization (EUA) for its Quidel QuickVue At-Home COVID-19 Test.
Patients using the antigen test can collect their own samples at home and do not need to send them off to a laboratory for analysis. The device is authorized for prescription home use with self-collected anterior nasal swabs from patients aged 14 and older or individuals 8 and up whose swabs are collected by an adult.
The test is authorized for patients suspected of COVID-19 infection within the first six days of symptoms appearing.